Protalix BioTherapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2015-09-30 was $0.00.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2014-12-31 was $3.00K, a 66.67% decline year-over-year.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2016 was $14.00K, a 97.38% decline from fiscal 2015.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2015 was $534.00K, a 1060.87% increase from fiscal 2014.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2014 was $46.00K, a 58.93% decline from fiscal 2013.
- Protalix BioTherapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2013 was $112.00K, a 90.66% decline from fiscal 2012.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2016-12-31 | $14.00K 10-K · filed 2019-03-18 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $534.00K 10-K · filed 2018-03-06 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2014-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $46.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $52.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $125.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2014-03-31 | $43.00K 10-Q · filed 2015-05-07 | $127.00K derived: sum of 4 quarters · filed 2016-03-08 |
| 2013-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | $112.00K 10-K · filed 2016-03-08 |
| 2013-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $165.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $174.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $28.00K 10-Q · filed 2014-05-08 | $1.22M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.20M 10-K · filed 2015-03-12 |
| 2012-09-30 | $82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $1.17M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | $1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.10M derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $7.00K 10-Q · filed 2013-05-09 | $58.00K derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $299.00K 10-K · filed 2014-03-13 |
| 2011-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $617.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $733.00K derived: sum of 4 quarters · filed 2013-02-28 |
| 2011-03-31 | $248.00K 10-Q · filed 2012-05-09 | |
| 2010-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $510.00K 10-K · filed 2013-02-28 |
| 2010-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | |
| 2009-12-31 | $293.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |